ARTICLE | Company News
Takara Bio, Otsuka deal
December 30, 2016 10:07 PM UTC
The companies partnered to co-develop Takara's HF10 oncolytic virus therapy in Japan to treat pancreatic, skin and other cancers. Otsuka will subsequently have exclusive rights to commercialize the mu...